Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Queensland Health
Boehringer Ingelheim
Harvard Business School

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040091

« Back to Dashboard

NDA 040091 describes SULFADIAZINE, which is a drug marketed by Abbvie, Everylife, Impax Labs, Lannett, Lederle, Lilly, and Sandoz, and is included in seven NDAs. It is available from one supplier. Additional details are available on the SULFADIAZINE profile page.

The generic ingredient in SULFADIAZINE is sulfadiazine sodium. There are seventeen drug master file entries for this compound. Additional details are available on the sulfadiazine sodium profile page.
Summary for 040091
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 040091
Medical Subject Heading (MeSH) Categories for 040091
Suppliers and Packaging for NDA: 040091
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFADIAZINE sulfadiazine TABLET;ORAL 040091 ANDA Eon Labs, Inc. 0185-0757 N 0185-0757-30
SULFADIAZINE sulfadiazine TABLET;ORAL 040091 ANDA Eon Labs, Inc. 0185-0757 N 0185-0757-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jul 29, 1994TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
US Army
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.